-
18680-5A prodrug for 5-ASA, which is effective against Crohn&rsquos disease and ulcerative colitis in animal models and clinical trials.
-
18680-50A prodrug for 5-ASA, which is effective against Crohn&rsquos disease and ulcerative colitis in animal models and clinical trials.
-
14566-1BAM7 is a direct activator of Bax (EC<sub>50</sub> = 3.3 µM) that engages the Bax trigger site and promotes the functional oligomerization of Bax.
-
14566-10BAM7 is a direct activator of Bax (EC<sub>50</sub> = 3.3 µM) that engages the Bax trigger site and promotes the functional oligomerization of Bax.
-
14566-25BAM7 is a direct activator of Bax (EC<sub>50</sub> = 3.3 µM) that engages the Bax trigger site and promotes the functional oligomerization of Bax.
-
14566-5BAM7 is a direct activator of Bax (EC<sub>50</sub> = 3.3 µM) that engages the Bax trigger site and promotes the functional oligomerization of Bax.
-
A0248-1 mgBovine adrenal medulla 12 peptide (BAM-12P) is a cleavage product of proenkephalin that binds &kappa-opioid receptors (&kappaORs). BAM-12P plays a role in antinociceptive signaling.
-
A0248-2 mgBovine adrenal medulla 12 peptide (BAM-12P) is a cleavage product of proenkephalin that binds &kappa-opioid receptors (&kappaORs). BAM-12P plays a role in antinociceptive signaling.
-
A0248-5 mgBovine adrenal medulla 12 peptide (BAM-12P) is a cleavage product of proenkephalin that binds &kappa-opioid receptors (&kappaORs). BAM-12P plays a role in antinociceptive signaling.
-
A0249-1 mg&kappaOR and µOR agonist and cleavage product of proenkephalin.
-
A0249-2 mg&kappaOR and µOR agonist and cleavage product of proenkephalin.
-
A0249-5 mg&kappaOR and µOR agonist and cleavage product of proenkephalin.